Manipulating anthracyclines for deeper tissue penetration and implications for glycolytic tissues
Proceedings of the National Academy of Sciences · 2025
DOI: 10.1073/pnas.2510263122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Erik R Abels und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell and Chemical Biology and Oncode Institute, Leiden University Medical Center, Leiden 2300 RC, The Netherlands. Hauptthemen laut MEDLINE: Anthracyclines, Glycolysis, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NWO | Exacte en Natuurwetenschappen (ENW), Hersenstichting (Hersenstichting Nederland).
Abstract (Originalsprache)
How drugs penetrate tissues is poorly understood yet important, since drugs that fail to reach their target will be ineffective. We followed the fate of anthracycline cancer drugs at high resolution by exploiting their intrinsic fluorescence. In a cell-based spheroid model, the soluble compound fluorescein penetrates the entire spheroid, unlike hydrophobic fluorescent lipids, which only enter the outermost cell layer. Anthracyclines have intermediate hydrophobicity. They enter the nucleus of a few outer cell layers at neutral pH, but penetrate the spheroids more deeply under acidic conditions, with a reduction in cell entry and cytotoxicity. The glycolytic conditions that prevail in the tumor microenvironment may thus limit cell entry and contribute to anthracycline drug resistance. We evaluated a library of anthracycline variants to determine the physicochemical properties related to tissue penetration depth. We find that this is determined by only three chemical properties: molar refractivity, topological polar surface area, and water solubility. Our findings suggest that modifications of anthracyclines may improve access and activity to deeply tissue-embedded targets such as pancreatic cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell and Chemical Biology and Oncode Institute, Leiden University Medical Center, Leiden 2300 RC, The Netherlands.
- Leiden Institute of Chemistry, Faculty of Science, Leiden University, Leiden 2333 RC, The Netherlands.
- Department of Neurosurgery, Leiden University Medical Center, Leiden 2300 RC, The Netherlands.
- Department of Neurosurgery, Haaglanden Medical Center, The Hague 2512 VA, The Netherlands.
ORCID-Profile: Jos H T Rohling, Sabina Y van der Zanden, Jacques Neefjes
Förderung
- NWO | Exacte en Natuurwetenschappen (ENW)
- Hersenstichting (Hersenstichting Nederland)
Zitieren
APA
Abels, E. R., Ter Linden, E., Rohling, J. H. T., Voortman, L. M., Janssen, L., Hornsveld, M., Overkleeft, H. S., van der Zanden, S. Y., Broekman, M. L. D., & Neefjes, J. (2025). Manipulating anthracyclines for deeper tissue penetration and implications for glycolytic tissues. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2510263122
Vancouver
Abels ER, Ter Linden E, Rohling JHT, Voortman LM, Janssen L, Hornsveld M, et al. Manipulating anthracyclines for deeper tissue penetration and implications for glycolytic tissues. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2510263122
BibTeX
@article{Abels2025,
author = {Abels, Erik R and Ter Linden, Esther and Rohling, Jos H T and Voortman, Lennard M and Janssen, Lennert and Hornsveld, Marten and Overkleeft, Herman S and van der Zanden, Sabina Y and Broekman, Marike L D and Neefjes, Jacques},
title = {Manipulating anthracyclines for deeper tissue penetration and implications for glycolytic tissues},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
doi = {10.1073/pnas.2510263122}
}
EUVIMED